Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242


Comprehensive analysis of microRNA (miRNA) targets in breast cancer cells.

Fan M, Krutilina R, Sun J, Sethuraman A, Yang CH, Wu ZH, Yue J, Pfeffer LM.

J Biol Chem. 2013 Sep 20;288(38):27480-93. doi: 10.1074/jbc.M113.491803. Epub 2013 Aug 6.


Dicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets.

Rowley JW, Chappaz S, Corduan A, Chong MM, Campbell R, Khoury A, Manne BK, Wurtzel JG, Michael JV, Goldfinger LE, Mumaw MM, Nieman MT, Kile BT, Provost P, Weyrich AS.

Blood. 2016 Apr 7;127(14):1743-51. doi: 10.1182/blood-2015-07-661371. Epub 2016 Jan 14.


Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.

Li XF, Yan PJ, Shao ZM.

Oncogene. 2009 Nov 5;28(44):3937-48. doi: 10.1038/onc.2009.245. Epub 2009 Aug 24.


Systematic identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding changes in transcript abundance.

Hendrickson DG, Hogan DJ, Herschlag D, Ferrell JE, Brown PO.

PLoS One. 2008 May 7;3(5):e2126. doi: 10.1371/journal.pone.0002126. Erratum in: PLoS ONE. 2008;3(11)


EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2.

Shen J, Xia W, Khotskaya YB, Huo L, Nakanishi K, Lim SO, Du Y, Wang Y, Chang WC, Chen CH, Hsu JL, Wu Y, Lam YC, James BP, Liu X, Liu CG, Patel DJ, Hung MC.

Nature. 2013 May 16;497(7449):383-7. doi: 10.1038/nature12080. Epub 2013 May 1.


Complexity in regulation of microRNA machinery components in invasive breast carcinoma.

Kwon SY, Lee JH, Kim B, Park JW, Kwon TK, Kang SH, Kim S.

Pathol Oncol Res. 2014 Jul;20(3):697-705. doi: 10.1007/s12253-014-9750-5. Epub 2014 Feb 27.


MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers.

Krutilina R, Sun W, Sethuraman A, Brown M, Seagroves TN, Pfeffer LM, Ignatova T, Fan M.

Breast Cancer Res. 2014 Jul 28;16(4):R78. doi: 10.1186/bcr3693.


Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates.

Karginov FV, Hannon GJ.

Genes Dev. 2013 Jul 15;27(14):1624-32. doi: 10.1101/gad.215939.113. Epub 2013 Jul 3.


Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas.

Prodromaki E, Korpetinou A, Giannopoulou E, Vlotinou E, Chatziathanasiadou Μ, Papachristou NI, Scopa CD, Papadaki H, Kalofonos HP, Papachristou DJ.

Cell Oncol (Dordr). 2015 Aug;38(4):307-17. doi: 10.1007/s13402-015-0231-y. Epub 2015 Jul 31.


MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype.

Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE, Green AR, Ellis IO, Tavaré S, Caldas C, Miska EA.

Genome Biol. 2007;8(10):R214.


Reduced DICER1 elicits an interferon response in endometrial cancer cells.

Chiappinelli KB, Haynes BC, Brent MR, Goodfellow PJ.

Mol Cancer Res. 2012 Mar;10(3):316-25. doi: 10.1158/1541-7786.MCR-11-0520. Epub 2012 Jan 17.


miR-346 Up-regulates Argonaute 2 (AGO2) Protein Expression to Augment the Activity of Other MicroRNAs (miRNAs) and Contributes to Cervical Cancer Cell Malignancy.

Guo J, Lv J, Liu M, Tang H.

J Biol Chem. 2015 Dec 18;290(51):30342-50. doi: 10.1074/jbc.M115.691857. Epub 2015 Oct 30.


Screening for possible miRNA-mRNA associations in a colon cancer cell line.

Kanematsu S, Tanimoto K, Suzuki Y, Sugano S.

Gene. 2014 Jan 10;533(2):520-31. doi: 10.1016/j.gene.2013.08.005. Epub 2013 Aug 9.


MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer.

Li X, Zhang Y, Shi Y, Dong G, Liang J, Han Y, Wang X, Zhao Q, Ding J, Wu K, Fan D.

J Cell Mol Med. 2011 Sep;15(9):1887-95. doi: 10.1111/j.1582-4934.2010.01194.x.


Knock-down of core proteins regulating microRNA biogenesis has no effect on sensitivity of lung cancer cells to ionizing radiation.

Surova O, Akbar NS, Zhivotovsky B.

PLoS One. 2012;7(3):e33134. doi: 10.1371/journal.pone.0033134. Epub 2012 Mar 30.


Genome-wide identification of targets and function of individual MicroRNAs in mouse embryonic stem cells.

Hanina SA, Mifsud W, Down TA, Hayashi K, O'Carroll D, Lao K, Miska EA, Surani MA.

PLoS Genet. 2010 Oct 21;6(10):e1001163. doi: 10.1371/journal.pgen.1001163.


MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer.

Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ.

J Biol Chem. 2008 Nov 7;283(45):31079-86. doi: 10.1074/jbc.M806041200. Epub 2008 Sep 12.


DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.

Sun X, Tang SC, Xu C, Wang C, Qin S, Du N, Liu J, Zhang Y, Li X, Luo G, Zhou J, Xu F, Ren H.

J Cell Mol Med. 2015 Jun;19(6):1357-65. doi: 10.1111/jcmm.12522. Epub 2015 Feb 20.


miR-150 promotes human breast cancer growth and malignant behavior by targeting the pro-apoptotic purinergic P2X7 receptor.

Huang S, Chen Y, Wu W, Ouyang N, Chen J, Li H, Liu X, Su F, Lin L, Yao Y.

PLoS One. 2013 Dec 2;8(12):e80707. doi: 10.1371/journal.pone.0080707. eCollection 2013.


Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival.

Sung H, Jeon S, Lee KM, Han S, Song M, Choi JY, Park SK, Yoo KY, Noh DY, Ahn SH, Kang D.

BMC Cancer. 2012 May 28;12:195. doi: 10.1186/1471-2407-12-195.

Items per page

Supplemental Content

Write to the Help Desk